Políticas públicas e direitos dos usuários do Sistema Único de Saúde com diabetes mellitus

Santos, Ellen Cristina Barbosa dos; Teixeira, Carla Regina de Souza; Zanetti, María Lúcia; Santos, Manoel Antônio dos; Pereira, Marta Cristiane Alves

doi:10.1590/s0034-71672011000500023

Cited by 7 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The reduction in mortality from endocrine, nutritional, and metabolic diseases following PNAISM implementation, as shown in this study, as well as in mortality from circulatory system diseases, may be associated with a reduction in shared risk factors, such as diabetes mellitus and dyslipidemia, 26 and with the health care provided to (Brazilian) diabetic patients, by making available pharmacological treatments (oral hypoglycemic drugs and insulin) to them through SUS. 26 The mortality analysis of neoplasms as a whole and not as separate entities, some of which top the priority list of women's health care in PNAISM, particularly cervical and breast cancers, is a limitation of the present study. However, PNAISM should reduce morbidity and mortality due to neoplasms in general.…”

Section: Discussionmentioning

confidence: 60%

National Policy of Comprehensive Women’s Health Care and Mortality in Menopause: Has Anything Changed?

Sorpreso

Figueiredo

Ramos

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: The National Policy of Comprehensive Women’s Health Care was implemented more than two decades ago, and the monitoring of potential benefits should be explored. Menopause is a period of life for which there are prevention and health promotion actions carried out by the government’s all-encompassing sole Unify Health System (UHS) and factored into Brazilian policies. It is thus our purpose to identify menopausal women’s main causes of death, as well as the mortality trend of such causes, especially after PNAISM implementation. Methods: This is an ecological study with secondary data analysis conducted by the Setor de Atenção Primária, Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia da Faculdade de Medicina da Universidade de São Paulo from 2018 to 2019. Data were retrieved from the Brazilian Health Department by accessing the mortality information system of the IT Department of SUS between 1996 and 2016, divided in two periods 1996 to 2004 and 2005 to 2006 according to implementation of the National Police. The data included the death records of Brazilian women aged 35 to 64 years who had a precise diagnosis (ICD-10). Trend and differences between periods were evaluated by linear regression. The significance level was set at 5%. Stata 11® (StataCorp, LCC) was used. Results: Menopausal women’s main causes of death were the circulatory system diseases (29.39%, 736,972 deaths), neoplasms (26.17%, 656,385 deaths), respiratory system diseases (7.29%, 182,812 deaths), endocrine (29.39%), nutritional, and metabolic (6.81%, 170,881 deaths) diseases, and external causes of morbidity and mortality (5.49%, 137,674 deaths). Implementation of PNAISM led to increasing reduction in mortality from circulatory system diseases (β=-0.58; 95% CI, -0.68 to -0.48; r²=0.93; p<0.001), but not to any significant changes in neoplasm mortalities (β=0.07; 95% CI, -0.01 to 0.15; r²=0.22; p=0.070). Conclusions: The leading causes of death among menopausal women are circulatory system diseases, neoplasms, respiratory system diseases, nutritional, metabolic, and endocrine diseases, and external causes of morbidity and mortality. The trend of mortality rates among menopausal women, following PNAISM implementation, was a decline in circulatory system diseases and in nutritional, metabolic, and endocrine diseases, with no changes for neoplasms and respiratory system diseases.

show abstract

Section: Discussionmentioning

confidence: 60%

National Policy of Comprehensive Women’s Health Care and Mortality in Menopause: Has Anything Changed?

Sorpreso

Figueiredo

Ramos

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The reduction in mortality from endocrine, nutritional, and metabolic diseases following PNAISM implementation, as shown in this study, as well as in mortality from circulatory system diseases, may be associated with a reduction in shared risk factors, such as diabetes mellitus and dyslipidemia, 35 and with the health care provided to (Brazilian) diabetic patients, by making available pharmacological treatments (oral hypoglycemic drugs and insulin) to them through SUS. 35 The mortality analysis of neoplasms as a whole and not as separate entities, some of which top the priority list of women's health care in PNAISM, particularly cervical and breast cancers, is a limitation of the present study. However, PNAISM should reduce morbidity and mortality due to neoplasms in general.…”

Section: Discussionmentioning

confidence: 60%

Brazilian National Policy of Comprehensive Women’s Health Care and Mortality in Menopause: Has Anything Changed?

Sorpreso

Figueiredo

Ramos

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: The National Policy for Integral Attention to Women’s Health was implemented more than two decades ago, and the monitoring of potential benefits should be explored. One of the life cycles of women contemplated in this health policy is the importance of health care during the climacteric. In fact, prevention and health promotion actions carried out by the Brazil National Health System - Unified Health System (SUS) and enshrined in health Brazilian policies for women. Thus, our purpose is to identify menopausal women’s main causes of death, as well as the mortality trend of such causes, especially after PNAISM implementation.Methods: Ecological study conducted by Disciplina de Ginecologia da Faculdade de Medicina da Universidade de São Paulo from 2018 to 2019. Data were retrieved from Brazilian Health Department by accessing the mortality information system of National Health Information, divided in periods 1996-2004 and 2005-2006 according to implementation of the National Police. The death records of Brazilian women aged 35 to 64 years who had a diagnosis (ICD-10). Trend and differences between periods were evaluated by linear regression. The significance level was 5%. (Stata 11® -StataCorp, LCC). Results: Main causes of women’s death were the circulatory system diseases (29.39%, 736,972 deaths), neoplasms (26.17%, 656,385 deaths), respiratory system diseases (7.29%, 182,812 deaths), endocrine (29.39%), nutritional, and metabolic (6.81%, 170,881 deaths) diseases, and external causes of morbidity and mortality (5.49%, 137,674 deaths). Implementation of PNAISM led to increasing reduction in mortality from circulatory system diseases (β=-0.58; 95% CI, -0.68 to -0.48; r²=0.93; p<0.001), and any significant changes in neoplasm mortalities (β=0.07; 95% CI, -0.01 to 0.15; r²=0.22; p=0.070). Conclusions: The leading causes of death during climacteric are circulatory system diseases, neoplasms, respiratory system diseases, nutritional, metabolic, and endocrine diseases, and external causes of morbidity and mortality, with no changes for neoplasms and respiratory system diseases. Thus, the analysis of women's health indicators, such as mortality rates, are fundamental in order to enable the monitoring of benefits and results related to PNAISM as well as directing the design and implementation of other new health policies to be developed for the women.

show abstract

“…Although all lawsuits have an impact on public health policies, in this study the qualitative phase was initiated in cases involving exclusively diabetes mellitus, since it is a disease with important advances and achievements in the last twenty five years in Brazil 9 , involving medicines and monitoring freely available by the public sector to all patients with the disease. Precisely for this reason access to treatment, hypothetically, should not be subject to judicial decisions.…”

Section: Comunicação Saúde Educação 2018; 22(64):165-76mentioning

confidence: 99%

A judicialização da Saúde na percepção de médicos prescritores

Neto

Gonçalves

Andrade

2017

Interface (Botucatu)

View full text Add to dashboard Cite

This paper analyzes the possible interference of the pharmaceutical industry in prescriptions drugs used in lawsuits against the Brazilian National Health System (SUS). It presents the survey used to build the database with lawsuits by drugs, procedures and equipment for the treatment of various diseases against the State of Minas Gerais. It is the analysis of the perception of the prescribers in order to know their respective positions in relation to the theme of the interference of the pharmaceutical industry in decisionmaking relating to lawsuits. The theoretical model and methodology used highlights the profile of the interviewees. Finally, it exposes in detail the analysis of the perceptions of prescribers, correlating them with the topic of the influence of the pharmaceutical industry in the current growth of lawsuits.

show abstract

Políticas públicas e direitos dos usuários do Sistema Único de Saúde com diabetes mellitus

Cited by 7 publications

References 17 publications

National Policy of Comprehensive Women’s Health Care and Mortality in Menopause: Has Anything Changed?

National Policy of Comprehensive Women’s Health Care and Mortality in Menopause: Has Anything Changed?

Brazilian National Policy of Comprehensive Women’s Health Care and Mortality in Menopause: Has Anything Changed?

A judicialização da Saúde na percepção de médicos prescritores

Contact Info

Product

Resources

About